⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanidine SCHEMBL6115162 | 0.75 | — | — | |
| Guanidine SCHEMBL29983942 | 0.72 | — | — | |
| Guanidine SCHEMBL5613752 | 0.72 | — | — | |
| Guanidine SCHEMBL2003 | 0.72 | — | — | |
| Guanidine SCHEMBL11330173 | 0.72 | — | — | |
| Guanidine SCHEMBL165720 | 0.72 | NOS2 (0.42) | — | |
| Guanidine SCHEMBL3390300 | 0.71 | — | — | |
| Guanidine SCHEMBL3878080 | 0.67 | — | — | |
| Guanidine SCHEMBL25310528 | 0.67 | — | — | |
| Guanidine SCHEMBL3310493 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3174848-B1 | METHOD FOR PRODUCING POLYGUANIDINES | SEALIFE PHARMA GMBH (AT) | 2018-08-01 | — | — | EP | claimed |
| EP-3174848-A1 | METHOD FOR PRODUCING POLYGUANIDINES | Sealife Pharma GmbH (AT) | 2017-06-07 | — | — | EP | claimed |
| WO-2016015081-A9 | METHOD FOR PRODUCING POLYGUANIDINES | SEALIFE PHARMA GMBH (AT) | 2016-03-31 | — | — | WO | claimed |
| WO-2016015081-A1 | METHOD FOR PRODUCING POLYGUANIDINES | SEALIFE PHARMA GMBH (AT) | 2016-02-04 | — | — | WO | claimed |
| EP-0984930-B1 | 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY | SUGEN INC (US) | 2005-04-06 | — | — | EP | claimed |
| CN-1278530-A | Novel peptide derivative | ASTRA AB (SE) | 2001-01-03 | — | — | CN | claimed |
| WO-2025034569-A9 | STING INHIBITORS AND METHODS OF USING THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025034569-A2 | STING INHIBITORS AND METHODS OF USING THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2025-02-13 | — | — | WO | disclosed |
| CN-117534866-A | Amino or amidine based porous polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-114966036-A | Quantitative chemical proteomics method for lipoylation modification sites | 北京大学 | 2022-08-30 | — | — | CN | disclosed |
| EP-2493849-B1 | METHOD OF SEPARATION EMPLOYING SWITCHABLE HYDROPHILICITY SOLVENTS | UNIV KINGSTON (CA) | 2021-12-08 | — | — | EP | disclosed |
| US-20210220272-A1 | BIPHASIX CANNABINOID DELIVERY | ALTUM PHARMACEUTICALS INC (CA) | 2021-07-22 | — | — | US | disclosed |
| EP-3630067-A1 | BIPHASIX CANNABINOID DELIVERY | Altum Pharmaceuticals Inc. (CA) | 2020-04-08 | — | — | EP | disclosed |
| US-4259482-A | NON-SPECIFIC DEPRESSION OF CENTRAL NERVOUS SYSTEM | MEAD JOHNSON & COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4246409-A | ANTIDIARRHEAL AGENTS | WILLIAM H. RORER, INC. (US) | 1981-01-20 | — | — | US | disclosed |
| US-4225315-A | Triazinones from amidinoureas | WILLIAM H. RORER, INC. (US) | 1980-09-30 | — | — | US | disclosed |
| US-4206142-A | REACTING A STYRYLSULFONYLAMIDINE WITH A BASE | MEAD JOHNSON & COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4130663-A | ANTITHROMBOGENIC, ANTIHYPERTENSIVE | MEAD JOHNSON & COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4096183-A | Styrylsulfonylamidines | MEAD JOHNSON & COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4052455-A | ANALGESICS, BLOOD PLATELET AGGREGATION INHIBITORS | MEAD JOHNSON & COMPANY (US) | 1977-10-04 | — | — | US | disclosed |